CD0271 0.3% / CD1579 2.5% Topical Gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD0271 0.3% / CD1579 2.5% Topical Gel, covering 2016-09-09 to 2016-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris [Phase 3]